PubMed:1946356
Annnotations
PMID_GLOBAL
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 29-45 | DiseaseOrPhenotypicFeature | denotes | immunodeficiency | 0021094 |
| T2 | 158-161 | DiseaseOrPhenotypicFeature | denotes | can | 0012833 |
| T3 | 238-254 | DiseaseOrPhenotypicFeature | denotes | immunodeficiency | 0021094 |
| T4 | 290-293 | DiseaseOrPhenotypicFeature | denotes | can | 0012833 |
| T5 | 1518-1521 | DiseaseOrPhenotypicFeature | denotes | can | 0012833 |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 96-102 | protein | denotes | 65-kDa |
| T2 | 108-131 | protein | denotes | 50-kDa NF-kappa B dimer |
| T3 | 414-425 | cell_line | denotes | THP-1 cells |
| T4 | 481-508 | protein | denotes | DNA-protein binding complex |
| T5 | 528-551 | DNA | denotes | HIV-1 promoter-enhancer |
| T6 | 582-591 | RNA | denotes | viral RNA |
| T7 | 649-666 | DNA | denotes | NF-kappa B region |
| T8 | 674-688 | DNA | denotes | HIV-1 enhancer |
| T9 | 694-735 | protein | denotes | 65-kDa plus 50-kDa NF-kappa B heterodimer |
| T10 | 777-795 | protein | denotes | NF-kappa B protein |
| T11 | 995-1006 | protein | denotes | heterodimer |
| T12 | 1051-1061 | protein | denotes | NF-kappa B |
| T13 | 1218-1228 | protein | denotes | NF-kappa B |
| T14 | 1262-1289 | protein | denotes | NF-kappa B binding proteins |
| T15 | 1335-1354 | protein | denotes | heterodimer complex |
| T16 | 1377-1405 | protein | denotes | NF-kappa B-binding complexes |
| T17 | 1465-1471 | protein | denotes | 65-kDa |
| T18 | 1477-1495 | protein | denotes | 50-kDa heterodimer |
| T19 | 1503-1517 | DNA | denotes | HIV-1 enhancer |
| T20 | 1549-1558 | cell_type | denotes | monocytes |
| T21 | 1596-1606 | DNA | denotes | HIV-1 gene |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-132 | Sentence | denotes | Negative regulation of human immunodeficiency virus type 1 expression in monocytes: role of the 65-kDa plus 50-kDa NF-kappa B dimer. |
| S2 | 133-338 | Sentence | denotes | Although monocytic cells can provide a reservoir for viral production in vivo, their regulation of human immunodeficiency virus type 1 (HIV-1) transcription can be either latent, restricted, or productive. |
| S3 | 339-410 | Sentence | denotes | These differences in gene expression have not been molecularly defined. |
| S4 | 411-603 | Sentence | denotes | In THP-1 cells with restricted HIV expression, there is an absence of DNA-protein binding complex formation with the HIV-1 promoter-enhancer associated with markedly less viral RNA production. |
| S5 | 604-760 | Sentence | denotes | This absence of binding was localized to the NF-kappa B region of the HIV-1 enhancer; the 65-kDa plus 50-kDa NF-kappa B heterodimer was preferentially lost. |
| S6 | 761-885 | Sentence | denotes | Adding purified NF-kappa B protein to nuclear extracts from cells with restricted expression overcomes this lack of binding. |
| S7 | 886-1071 | Sentence | denotes | In addition, treatment of these nuclear extracts with sodium deoxycholate restored their ability to form the heterodimer, suggesting the presence of an inhibitor of NF-kappa B activity. |
| S8 | 1072-1238 | Sentence | denotes | Furthermore, treatment of nuclear extracts from these cells that had restricted expression with lipopolysaccharide increased viral production and NF-kappa B activity. |
| S9 | 1239-1365 | Sentence | denotes | Antiserum specific for NF-kappa B binding proteins, but not c-rel-specific antiserum, disrupted heterodimer complex formation. |
| S10 | 1366-1449 | Sentence | denotes | Thus, both NF-kappa B-binding complexes are needed for optimal viral transcription. |
| S11 | 1450-1618 | Sentence | denotes | Binding of the 65-kDa plus 50-kDa heterodimer to the HIV-1 enhancer can be negatively regulated in monocytes, providing one mechanism restricting HIV-1 gene expression. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C2 | 23-58 | NP | denotes | human immunodeficiency virus type 1 |
| C1 | 23-69 | NP | denotes | human immunodeficiency virus type 1 expression |
| C3 | 73-82 | NP | denotes | monocytes |
| C4 | 92-131 | NP | denotes | the 65-kDa plus 50-kDa NF-kappa B dimer |
| C5 | 142-157 | NP | denotes | monocytic cells |
| C6 | 186-210 | NP | denotes | viral production in vivo |
| C7 | 212-217 | NP | denotes | their |
| C9 | 232-275 | NP | denotes | human immunodeficiency virus type 1 (HIV-1) |
| C8 | 232-289 | NP | denotes | human immunodeficiency virus type 1 (HIV-1) transcription |
| C12 | 442-445 | NP | denotes | HIV |
| C11 | 431-456 | NP | denotes | restricted HIV expression |
| C10 | 414-456 | NP | denotes | THP-1 cells with restricted HIV expression |
| C14 | 528-533 | NP | denotes | HIV-1 |
| C13 | 524-551 | NP | denotes | the HIV-1 promoter-enhancer |
| C15 | 582-602 | NP | denotes | viral RNA production |
| C17 | 674-679 | NP | denotes | HIV-1 |
| C16 | 670-688 | NP | denotes | the HIV-1 enhancer |
| C18 | 690-735 | NP | denotes | the 65-kDa plus 50-kDa NF-kappa B heterodimer |
| C19 | 799-815 | NP | denotes | nuclear extracts |
| C20 | 821-853 | NP | denotes | cells with restricted expression |
| C21 | 912-934 | NP | denotes | these nuclear extracts |
| C22 | 969-974 | NP | denotes | their |
| C23 | 991-1006 | NP | denotes | the heterodimer |
| C24 | 1051-1070 | NP | denotes | NF-kappa B activity |
| C25 | 1098-1114 | NP | denotes | nuclear extracts |
| C27 | 1120-1131 | NP | denotes | these cells |
| C28 | 1132-1136 | NP | denotes | that |
| C26 | 1120-1162 | NP | denotes | these cells that had restricted expression |
| C29 | 1197-1213 | NP | denotes | viral production |
| C30 | 1218-1237 | NP | denotes | NF-kappa B activity |
| C31 | 1461-1495 | NP | denotes | the 65-kDa plus 50-kDa heterodimer |
| C33 | 1503-1508 | NP | denotes | HIV-1 |
| C32 | 1499-1517 | NP | denotes | the HIV-1 enhancer |
| C34 | 1549-1558 | NP | denotes | monocytes |
| C36 | 1596-1601 | NP | denotes | HIV-1 |
| C35 | 1596-1617 | NP | denotes | HIV-1 gene expression |
| R1 | C5 | C3 | coref-ident | monocytic cells,monocytes |
| R2 | C7 | C5 | coref-pron | their,monocytic cells |
| R3 | C9 | C2 | coref-ident | human immunodeficiency virus type 1 (HIV-1),human immunodeficiency virus type 1 |
| R4 | C8 | C1 | coref-other | human immunodeficiency virus type 1 (HIV-1) transcription,human immunodeficiency virus type 1 expression |
| R5 | C12 | C9 | coref-ident | HIV,human immunodeficiency virus type 1 (HIV-1) |
| R6 | C11 | C1 | coref-other | restricted HIV expression,human immunodeficiency virus type 1 expression |
| R7 | C14 | C12 | coref-ident | HIV-1,HIV |
| R8 | C15 | C6 | coref-other | viral RNA production,viral production in vivo |
| R9 | C17 | C14 | coref-ident | HIV-1,HIV-1 |
| R10 | C16 | C13 | coref-ident | the HIV-1 enhancer,the HIV-1 promoter-enhancer |
| R11 | C18 | C4 | coref-ident | the 65-kDa plus 50-kDa NF-kappa B heterodimer,the 65-kDa plus 50-kDa NF-kappa B dimer |
| R12 | C20 | C10 | coref-ident | cells with restricted expression,THP-1 cells with restricted HIV expression |
| R13 | C21 | C19 | coref-ident | these nuclear extracts,nuclear extracts |
| R14 | C22 | C21 | coref-pron | their,these nuclear extracts |
| R15 | C23 | C18 | coref-ident | the heterodimer,the 65-kDa plus 50-kDa NF-kappa B heterodimer |
| R16 | C25 | C21 | coref-ident | nuclear extracts,these nuclear extracts |
| R17 | C28 | C27 | coref-relat | that,these cells |
| R18 | C26 | C20 | coref-ident | these cells that had restricted expression,cells with restricted expression |
| R19 | C29 | C6 | coref-ident | viral production,viral production in vivo |
| R20 | C30 | C24 | coref-ident | NF-kappa B activity,NF-kappa B activity |
| R21 | C31 | C23 | coref-ident | the 65-kDa plus 50-kDa heterodimer,the heterodimer |
| R22 | C33 | C17 | coref-ident | HIV-1,HIV-1 |
| R23 | C32 | C16 | coref-ident | the HIV-1 enhancer,the HIV-1 enhancer |
| R24 | C34 | C5 | coref-ident | monocytes,monocytic cells |
| R25 | C36 | C33 | coref-ident | HIV-1,HIV-1 |
| R26 | C35 | C1 | coref-ident | HIV-1 gene expression,human immunodeficiency virus type 1 expression |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-19 | other_name | denotes | Negative regulation |
| T2 | 23-58 | virus | denotes | human immunodeficiency virus type 1 |
| T3 | 96-102 | protein_subunit | denotes | 65-kDa |
| T4 | 108-114 | protein_complex | denotes | 50-kDa |
| T5 | 115-125 | protein_molecule | denotes | NF-kappa B |
| T6 | 232-267 | virus | denotes | human immunodeficiency virus type 1 |
| T7 | 269-274 | virus | denotes | HIV-1 |
| T8 | 414-425 | cell_line | denotes | THP-1 cells |
| T9 | 442-456 | other_name | denotes | HIV expression |
| T10 | 481-508 | protein_complex | denotes | DNA-protein binding complex |
| T11 | 528-533 | virus | denotes | HIV-1 |
| T12 | 582-591 | RNA_family_or_group | denotes | viral RNA |
| T13 | 649-659 | protein_molecule | denotes | NF-kappa B |
| T14 | 674-679 | virus | denotes | HIV-1 |
| T15 | 694-712 | protein_complex | denotes | 65-kDa plus 50-kDa |
| T16 | 713-723 | protein_molecule | denotes | NF-kappa B |
| T17 | 777-787 | protein_molecule | denotes | NF-kappa B |
| T18 | 799-815 | cell_component | denotes | nuclear extracts |
| T19 | 832-853 | other_name | denotes | restricted expression |
| T20 | 918-934 | cell_component | denotes | nuclear extracts |
| T21 | 940-959 | other_organic_compound | denotes | sodium deoxycholate |
| T22 | 995-1006 | protein_complex | denotes | heterodimer |
| T23 | 1051-1061 | protein_molecule | denotes | NF-kappa B |
| T24 | 1098-1114 | cell_component | denotes | nuclear extracts |
| T25 | 1141-1162 | other_name | denotes | restricted expression |
| T26 | 1168-1186 | lipid | denotes | lipopolysaccharide |
| T27 | 1218-1228 | protein_molecule | denotes | NF-kappa B |
| T28 | 1262-1272 | protein_molecule | denotes | NF-kappa B |
| T29 | 1299-1323 | other_organic_compound | denotes | c-rel-specific antiserum |
| T30 | 1335-1354 | protein_complex | denotes | heterodimer complex |
| T31 | 1377-1387 | protein_molecule | denotes | NF-kappa B |
| T32 | 1421-1448 | other_name | denotes | optimal viral transcription |
| T33 | 1465-1471 | protein_subunit | denotes | 65-kDa |
| T34 | 1477-1495 | protein_complex | denotes | 50-kDa heterodimer |
| T35 | 1503-1508 | virus | denotes | HIV-1 |
| T36 | 1549-1558 | cell_type | denotes | monocytes |
| T37 | 1596-1601 | virus | denotes | HIV-1 |